<html lang='en'><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><title>Vitamin C and zinc don’t reduce coronavirus symptoms, Cleveland Clinic study says</title></head><body><h1>Vitamin C and zinc don’t reduce coronavirus symptoms, Cleveland Clinic study says</h1><p>Vitamin C and zinc don’t reduce coronavirus symptoms, Cleveland Clinic study says</p><p><figcaption>&nbsp;&nbsp;&nbsp;&nbsp;Bottles of vitamin C are displayed at Vibrant Health April 6, 2009 in San Francisco, California.(Photo by Justin Sullivan/Getty Images) Getty Images</figcaption></p><p>&nbsp;&nbsp;&nbsp;&nbsp;CLEVELAND, Ohio – Treating coronavirus patients with vitamin C and zinc does not reduce the severity or duration of their symptoms, Cleveland Clinic researchers determined in a new study.</p><p>&nbsp;&nbsp;&nbsp;The study, published Friday in JAMA Open Network, is the first to test the effectiveness of using zinc and vitamin C to treat COVID-19.Researchers ended the trial after six months because they determined zinc, vitamin C or a combination of both had no benefit to coronavirus patients beyond standard care.</p><p>&nbsp;&nbsp;&nbsp;Since the start of the COVID-19 pandemic, there has been speculation whether certain vitamins, supplements or medications could be used to prevent infection or treat symptoms.Experts have taken a cautious approach to recommending any supplemental treatment because there was no data to support using them to treat COVID-19.</p><p>&nbsp;&nbsp;&nbsp;Clinic researchers, beginning in April 2020, decided to test the use of zinc and vitamin C to treat coronavirus patients.Zinc helps the immune system fight off bacteria and viruses, and vitamin C has been found to benefit the immune system.</p><p>&nbsp;&nbsp;&nbsp;The randomized trial involved 214 coronavirus patients split into four groups, with each getting a specific treatment for 10 days.The first group received high doses of zinc; the second received high doses of vitamin C; the third received both zinc and vitamin C; and the fourth received standard care.</p><p>&nbsp;&nbsp;&nbsp;Clinic researchers ended the trial in October 2020 because vitamin C and zinc did not reduce the severity of patients’ symptoms or the duration of those symptoms, the study says.</p><p>&nbsp;&nbsp;&nbsp;The study did not involve any patients who were hospitalized; all of the participants were treated on an outpatient basis.The patients had an average age of 45.2 years old, and nearly 62% were women.</p><p>&nbsp;&nbsp;&nbsp;After all the early speculation on various supplements, the research is just catching up to provide data, said Dr. Milind Desai, the director of clinical operations in the Clinic’s heart, vascular and thoracic institute.</p><p>&nbsp;&nbsp;&nbsp;'While vitamin C and zinc proved ineffective as a treatment when clinically compared to standard care, the study of other therapeutics continues,' Desai said in a news release.</p><p><p><strong><i>Posted On: </i></strong>2021-02-12T00:00:00<br></p><p><strong><i>Posted By: </i></strong>Evan MacDonald</p></p><p><p><img src='http://localhost:8083/blackboxP3/jpg/L0C04CV6R.jpg' style='max-width: 480px;'/></p><p><img src='http://localhost:8083/blackboxP3/jpg/L0C04CV6S.jpg' style='max-width: 480px;'/></p><p><strong>Content Date:</strong>&nbsp;2021-02-12</p><p><strong>Download Date:</strong>&nbsp;2021-05-30</p><p><strong>Document ID:</strong>&nbsp;L0C04CV6L</p></body></html>